To the Editor,The search for ideal cancer chemoproventive compounds, that is, effective at low doses, with little or no toxicity, easily administrable and low cost (Wang & Chen, 2013), has led to an exponential interest in non-nutritive components of natural origin, generically identifiable in the class of phytochemicals. This started a boundless research field, stimulating thousands of studies and producing numerous results in support of the cancer chemopreventive potential of different botanical species, such as Brassicaceae (Cocchi et al., 2020).Great interest has been addressed to different mushrooms species (Nowakowski et al., 2021), including those belonging to the Polyporales order (Basidiomycota philum), such as the famous Ganoderma lucidum (known as Reishi), which has been employed in Chinese and Japanese folk medicine since ancient times. The popular opinion attributes to G. lucidum almost "miraculous" properties and numerous studies are available concerning its anti-inflammatory, antioxidant, antibacterial, antiviral and neuroprotective properties (Cör Andrejč et al., 2022). In addition, cancer chemopreventive effects have been